Literature DB >> 24298469

Nosocomial Infections and Drug Susceptibility Patterns in Methicillin Sensitive and Methicillin Resistant Staphylococcus aureus.

Nitish Kumar Sharma1, Raina Garg, Shrikala Baliga, Gopalkrishna Bhat K.   

Abstract

AIM: Staphylococcus aureus is one of the leading causes of nosocomial infections and is known for its ability to develop resistance to antibiotics. The drug susceptibility pattern of Methicillin Sensitive S. aureus (MSSA) and Methicillin Resistant S. aureus (MRSA) may vary. AIMs and
Objectives: This study was carried out to determine and compare the drug susceptibility patterns in nosocomial MSSA and MRSA.
MATERIAL AND METHODS: The study was conducted between September 2009 and August 2011. Standard conventional methods were used for the isolation and identification of S. aureus. MRSA was identified by the cefoxitin (30 μg) disk method. Antibiotic susceptibility test was done using Kirby-Bauer disk diffusion method and the interpretation of the results was done using CLSI guidelines.
RESULTS: Out of 685 strains of S. aureus studied, 173(25.25%) were MRSA and 512 (74.25%) were MSSA. Out of 173 MRSA strains, 114(65.89%) were isolated from pus, 22(12.71%) from vaginal swab, 18(10.40%) from central catheter tip and the remaining from other specimens. All isolates were susceptible to vancomycin and least number of isolates were susceptible to penicillin. MRSA displayed significantly higher resistance to other antibiotics. 45.7% of MRSA strains were resistant to clindamycin, 64.7% to ciprofloxacin, 87.3% to cotrimoxazole, 54.3% to erythromycin, 17.3% to gentamicin, 16.8% to netilmycin, and 58.38% to tetracycline. Inducible clindamycin resistance was detected in 37 (21.38%) strains of MRSA.
CONCLUSION: Nosocomial infections caused by MRSA is a significant problem. MRSA and MSSA differ with their susceptibility to antibiotics. All MRSA isolates in our hospitals were susceptible to vancomycin. Proper selection of the antibiotics based on antibiotic susceptibility test results is needed for effective treatment and prevention of emergence of resistance in MRSA and MSSA.

Entities:  

Keywords:  Drug Susceptibility; Methicillin-Resistant Staphylococcus aureus; Nosocomial Infections

Year:  2013        PMID: 24298469      PMCID: PMC3843450          DOI: 10.7860/JCDR/2013/6750.3463

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence.

Authors:  Sanjay K Shukla
Journal:  Clin Med Res       Date:  2005-05

2.  Study of methicillin resistant S. aureus (MRSA) isolates from high risk patients.

Authors:  S Vidhani; P L Mehndiratta; M D Mathur
Journal:  Indian J Med Microbiol       Date:  2001 Apr-Jun       Impact factor: 0.985

3.  Emergence of vancomycin-intermediate Staphylococcus species in southern India.

Authors:  G A Menezes; B N Harish; S Sujatha; K Vinothini; S C Parija
Journal:  J Med Microbiol       Date:  2008-07       Impact factor: 2.472

4.  Antimicrobial susceptibility pattern of clinical isolates of methicillin resistant Staphylococcus aureus.

Authors:  Samia Perwaiz; Qamaruddin Barakzi; Badar Jehan Farooqi; Nazia Khursheed; Nasim Sabir
Journal:  J Pak Med Assoc       Date:  2007-01       Impact factor: 0.781

Review 5.  Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Peter C Appelbaum
Journal:  Int J Antimicrob Agents       Date:  2007-09-20       Impact factor: 5.283

6.  Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh.

Authors:  S Anupurba; M R Sen; G Nath; B M Sharma; A K Gulati; T M Mohapatra
Journal:  Indian J Med Microbiol       Date:  2003 Jan-Mar       Impact factor: 0.985

Review 7.  Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.

Authors:  Frank R DeLeo; Henry F Chambers
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

8.  Prevalence and Antimicrobial Susceptibility Pattern of Methicillin-resistant Staphylococcus Aureus [MRSA] Isolates at a Tertiary Care Hospital in Mangalore, South India.

Authors:  Vidya Pai; Venkatakrishna I Rao; Sunil P Rao
Journal:  J Lab Physicians       Date:  2010-07

9.  High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India.

Authors:  Hare Krishna Tiwari; Darshan Sapkota; Malaya Ranjan Sen
Journal:  Infect Drug Resist       Date:  2008-11-30       Impact factor: 4.003

10.  Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.

Authors:  Hare Krishna Tiwari; Malay Ranjan Sen
Journal:  BMC Infect Dis       Date:  2006-10-26       Impact factor: 3.090

View more
  5 in total

1.  Inducible Clindamycin Resistance among Clinical Isolates of Staphylococcus aureus from Sub Himalayan Region of India.

Authors:  Kiran K Mokta; Santwana Verma; Divya Chauhan; Sunite A Ganju; Digvijay Singh; Anil Kanga; Anita Kumari; Vinod Mehta
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Healthcare-Associated Methicillin-Resistant Staphylococcus aureus: Clinical characteristics and antibiotic resistance profile with emphasis on macrolide-lincosamide-streptogramin B resistance.

Authors:  Jyoti Kumari; Shalini M Shenoy; Shrikala Baliga; M Chakrapani; Gopalkrishna K Bhat
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

3.  Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.

Authors:  Mical Paul; Jihad Bishara; Dafna Yahav; Elad Goldberg; Ami Neuberger; Nesrin Ghanem-Zoubi; Yaakov Dickstein; William Nseir; Michael Dan; Leonard Leibovici
Journal:  BMJ       Date:  2015-05-14

Review 4.  Understanding the Fight Against Resistance: Hospital-Acquired Methicillin-Resistant Staphylococcus Aureus vs. Community-Acquired Methicillin-Resistant Staphylococcus Aureus.

Authors:  Nicholas Tsouklidis; Rajat Kumar; Stacey E Heindl; Ravi Soni; Safeera Khan
Journal:  Cureus       Date:  2020-06-27

5.  Prevalence and antibiogram study of Staphylococcus aureus isolated from clinical and selected drinking water of Dutsin-Ma, Katsina state, Nigeria.

Authors:  A T Adesoji; J P Onuh; J Bagu; S A Itohan
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.